A framework program for the teaching of alternative methods (replacement, reduction, refinement) to animal experimentation

Altex

Volumn 28, Issue 4, 2011, Pages 341-352

  Daneshian, Mardas ^a   Akbarsha, Mohammad A ^b   Blaauboer, Bas ^c   Caloni, Francesca ^d   Cosson, Pierre ^e   Curren, Rodger ^f   Goldberg, Alan ^g   Gruber, Franz ^h   Ohl, Frauke ⁱ   Pfaller, Walter ^j   Van Der Valk, Jan ^k   Vinardell, Pilar ^l   Zurlo, Joanne ^g   Hartung, Thomas ^a,g   Leist, Marcel ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b BHARATHIDASAN UNIVERSITY   (India)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^f Institute for in Vitro Sciences   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h Doerenkamp Zbinden Foundation   (Switzerland)

ⁱ UTRECHT UNIVERSITY   (Netherlands)

^j INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^k UTRECHT UNIVERSITY   (Netherlands)

^l UNIVERSITY OF BARCELONA   (Spain)

more..

Author keywords

3Rs; Education; Teaching; Toxicology

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TESTING ALTERNATIVE; ANIMAL TESTING REDUCTION; ANIMAL TESTING REFINEMENT; ANIMAL TESTING REPLACEMENT; BASIC RESEARCH; CONFERENCE PAPER; EDUCATION PROGRAM; EUROPE; MEDICAL ETHICS; NONHUMAN; TEACHING; TOXICITY TESTING;

EID: 84455209587     PISSN: 09467785     EISSN: None     Source Type: Journal    
DOI: 10.14573/altex.2011.4.341     Document Type: Conference Paper

References (79)

1. Adler, S., Basketter, D., Creton, S., et al. (2011). Alternative (non-animal) methods for cosmetics testing: current status and future prospects - 2010. Arch. Toxicol. 85, 367-485.
2. Bahramsoltani, M., Plendl, J., Janczyk, P., et al. (2009). Quantitation of angiogenesis and antiangiogenesis in vivo, ex vivo and in vitro - an overview. ALTEX 26, 95-107.
3. Balls, M., Amcoff, P., Bremer, S., et al. (2006). The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58. ATLA 34, 603-620. (Pubitemid 46238600)
4. Bauer, M. S. (1993). A survey of the use of live animals, cadavers, inanimate models, and computers in teaching veterinary surgery. J. Am. Vet. Med. Assoc. 203, 1047-1051.
5. Boekelheide, K. and Andersen, M. E. (2010). A mechanistic redefinition of adverse effects - a key step in the toxicity testing paradigm shift. ALTEX 27, 243-252.
6. Bottini, A. A., Amcoff, P., and Hartung, T. (2007). Food for thought ... on globalisation of alternative methods. ALTEX 24, 255-269.
7. Bottini, A. A. and Hartung, T. (2009). Food for thought ... on the economics of animal testing. ALTEX 26, 3-16.
8. Brunner, D., Frank, J., Appl, H., et al. (2010). Serum-free cell culture: the serum-free media interactive online database. ALTEX 27, 53-62.
9. Coecke, S., Balls, M., Bowe, G., et al. (2005). Guidance on good cell culture practice. a report of the second ECVAM task force on good cell culture practice. ATLA 33, 261-287. (Pubitemid 40964979)
10. Daneshian, M., Leist, M., and Hartung, T. (2010). The Center for Alternatives to Animal Testing - Europe (CAAT-EU): a transatlantic bridge for the paradigm shift in toxicology. ALTEX 27, 63-69.
11. st century assessment of "Endocrine disruption". ALTEX 27, 264-278.
12. Ducceschi, L., Green, N., and Miller-Spiegel, C. (2010). Dying to learn: the supply and use of companion animals in U.S. colleges and universities. ALTEX 27, 304-308.
13. Falsig, J., Latta, M., and Leist, M. (2004a). Defined inflammatory states in astrocyte cultures: correlation with susceptibility towards CD95-driven apoptosis. J. Neurochem. 88, 181-193. (Pubitemid 38030221)
14. Falsig, J., Pörzgen, P., Lotharius, J., and Leist, M. (2004b). Specific modulation of astrocyte inflammation by inhibition of mixed lineage kinases with CEP-1347. J. Immunol. 173, 2762-2770. (Pubitemid 39063138)
15. Falsig, J., Pörzgen, P., Lund, S., et al. (2006). The inflammatory transcriptome of reactive murine astrocytes and implications for their innate immune function. J. Neurochem. 96, 893-907.
16. Festing, S. and Wilkinson, R. (2007). The ethics of animal research. Talking Point on the use of animals in scientific research. EMBO Rep. 8, 526-530. (Pubitemid 47214702)
17. Gruber, F. P. and Dewhurst, D. G. (2004). Alternatives to animal experimentation in biomedical education. ALTEX 21, Suppl. 1, 33-48. (Pubitemid 40074945)
18. Hagelschuer, I., Hauff, P., Strube, A., et al. (2009). Luminescent imaging technology as an opportunity to reduce and refine animal experiments: Light at the end of the tunnel? ALTEX 26, 177-185.
19. Hamann, M., Lange, N., Kuschka, J., et al. (2010). Non-invasive genotyping of transgenic mice: comparison of different commercial kits and required amounts. ALTEX 27, 185-190.
20. Hart, L. A., Wood, M. W., and Weng, H. Y. (2005). Mainstreaming alternatives in veterinary medical education: resource development and curricular reform. J. Vet. Med. Educ. 32, 473-480. (Pubitemid 43339927)
21. Hartung, T., Bremer, S., Casati, S., et al. (2004). A modular approach to the ECVAM principles on test validity. ATLA 32, 467-472. (Pubitemid 40128842)
22. Hartung, T. (2007). Food for thought ... on validation. ALTEX 24, 67-80.
23. Hartung, T. and Leist, M. (2008). Food for thought ... on the evolution of toxicology and the phasing out of animal testing. ALTEX 25, 91-102.
24. Hartung, T., Blaauboer, B., and Leist, M. (2009). Food for thought ... on education in alternative methods in toxicology. ALTEX 26, 255-263.
25. Hartung, T. and Hoffmann, S. (2009). Food for thought ... on in silico methods in toxicology. ALTEX 26, 155-166.
26. Hartung, T. and Rovida, C. (2009). Chemical regulators have overreached. Nature 460, 1080-1081.
27. Hartung, T. (2010a). Food for thought ... on alternative methods for chemical safety testing. ALTEX 27, 3-14.
28. 4 report. ALTEX 27, 285-303.
29. st century? ALTEX 27, 253-263.
30. Hartung, T. (2010d). Food for thought ... on alternative methods for nanoparticle safety testing. ALTEX 27, 87-95.
31. Hartung, T., Bruner, L., Curren, R., et al. (2010). First alternative method validated by a retrospective weight-of-evidence approach to replace the Draize eye test for the identification of non-irritant substances for a defined applicability domain. ALTEX 27, 43-51.
32. Hartung, T. and McBride, M. (2011). Food for thought ... on mapping the human toxome. ALTEX 28, 83-93.
33. Hartung, T., Blaauboer, B. J., and Bosgra, S. (2011). An expert consortium review of the EC-commissioned report "Alternative (Non-Animal) Methods for Cosmetics Testing: Current Status and Future Prospects - 2010". ALTEX 28, 183-209.
34. Hendriksen, C. F. (2006). Towards eliminating the use of animals for regulatory required vaccine quality control. ALTEX 23, 187-190.
35. Henn, A., Lund, S., Hedtjarn, M., et al. (2009). The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX 26, 83-94.
36. Hoffmann, S., Peterbauer, A., Schindler, S., et al. (2005). International validation of novel pyrogen tests based on human monocytoid cells. J. Immunol. Methods 298, 161-173. (Pubitemid 40545102)
37. Hoffmann, S., Edler, L., Gardner, I., et al. (2008). Points of reference in the validation process: the report and recommendations of ECVAM Workshop 66. ATLA 36, 343-352.
38. Jaworska, J. and Hoffmann, S. (2010). Integrated Testing Strategy (ITS) - Opportunities to better use existing data and guide future testing in toxicology. ALTEX 27, 231-242.
39. Jukes, N. and Chiuia, M. (2003). From guinea pig to computer Mouse: Alternative methods for progressive human Education. Leicester: InterNICHE
40. Kamusella, P. C., Wissgott, C., Grosse-Siestrup, C., et al. (2009). A model of isolated, autologously hemoperfused porcine slaughter-house lungs. ALTEX 26, 279-284.
41. Karleta, V., Andrlik, I., Braunmuller, S., et al. (2010). Poloxamer 188 supplemented culture medium increases the vitality of Caco-2 cells after subcultivation and freeze/thaw cycles. ALTEX 27, 191-197.
42. Knight, A. (2007). The effectiveness of humane teaching methods in veterinary education. ALTEX 24, 91-109.
43. Knight, A. (2008). Non-animal methodologies within biomedical research and toxicity testing. ALTEX 25, 213-231.
44. Kohler, G. and Milstein, C. (2005). Continuous cultures of fused cells secreting antibody of predefined specificity. 1975. J. Immunol. 174, 2453-2455.
45. Kretlow, A., Butzke, D., Goetz, M. E., et al. (2010). Implementation and enforcement of the 3Rs principle in the field of transgenic animals used for scientific purposes. Report and recommendations of the BfR expert workshop, May 18-20, 2009, Berlin, Germany. ALTEX 27, 117-134.
46. Krewski, D., Acosta, D., Jr, Andersen, M., et al. (2010). Toxicity testing in the 21st century: a vision and a strategy. J. Toxicol. Environ. Health B Crit. Rev. 13, 51-138.
47. Leist, M., Bremer, S., Brundin, P., et al. (2008a). The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. ALTEX 25, 163-190.
48. Leist, M., Kadereit, S., and Schildknecht, S. (2008b). Food for thought ... on the real success of 3R approaches. ALTEX 25, 17-32.
49. Leist, M., Hartung, T., and Nicotera, P. (2008c). The dawning of a new age of toxicology. ALTEX 25, 103-114.
50. Leist, M., Efremova, L., and Karreman, C. (2010). Food for thought ... considerations and guidelines for basic test method descriptions in toxicology. ALTEX 27, 309-317.
51. Lima, W. C., Lelong, E., and Cosson, P. (2011). What can Dictyostelium bring to the study of Pseudomonas infections? Semin. Cell Dev. Biol. 22, 77-81.
52. Locke, P. and Myers D. B. (2011). A replacement-first approach to toxicity testing is necessary to successfully reauthorize TSCA. ALTEX 28, 266-272.
53. Lotharius, J., Falsig, J., van Beek, J., et al. (2005). Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J. Neurosci. 25, 6329-6342. (Pubitemid 40962528)
54. Lund, S., Christensen, K. V., Hedtjärn, M., et al. (2006). The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions. J. Neuroimmunol. 180, 71-87. (Pubitemid 44692327)
55. Manzer, A. K., Lombardi-Borgia, S., Schafer-Korting, M., et al. (2009). SV40-transformed human corneal keratocytes: optimisation of serum-free culture conditions. ALTEX 26, 33-39.
56. Martinsen, S. and Jukes, N. (2005). Towards a humane veterinary education. J. Vet. Med. Educ. 32, 454-460. (Pubitemid 43339924)
57. Maynard, J. and Georgiou, G. (2000). Antibody engineering. Annu. Rev. Biomed. Eng. 2, 339-376.
58. NRC (2007). Toxicity testing in the twenty-first century: A vision and a strategy. Washington, DC: National Academies Press.
59. 4). ALTEX 26, 187-208.
60. Sauer, U. G. (2009a). Animal and non-animal experiments in nanotechnology - the results of a critical literature survey. ALTEX 26, 109-128.
61. Sauer, U. G. (2009b). Political incentives towards replacing animal testing in nanotechnology? ALTEX 26, 285-294.
62. Sauer, U. G., Wachter, T., Grune, B., et al. (2009). Go3R - semantic Internet search engine for alternative methods to animal testing. ALTEX 26, 17-31.
63. Schindler, S., Spreitzer, I., Loschner, B., et al. (2006). International validation of pyrogen tests based on cryopreserved human primary blood cells. J. Immunol. Methods 316, 42-51. (Pubitemid 44573216)
64. Schindler, S., von Aulock, S., Daneshian, M., et al. (2009). Development, validation and applications of the monocyte activation test for pyrogens based on human whole blood. ALTEX 26, 265-277.
65. Schmidt, A., Hohensee, C., Teichgräber, U., and Schmidt, A. (2011). SATIS ethics ranking of universities in Germany regarding animal use in education. ALTEX 28, 243-244.
66. Shoemaker, C. B. (2005). When will rAbs replace mAbs in labs? Vet. J. 170, 151-152.
67. Siegel, D. L. (2002). Recombinant monoclonal antibody technology. Transfus. Clin. Biol. 9, 15-22.
68. Silbergeld, E. K., Contreras, E. Q., Hartung, T., et al. (2011). Nanotoxicology: "The end of the beginning" - Signs on the roadmap to a strategy for assuring the safe application and use of nanomaterials. ALTEX 28, 236-241.
69. Skelin, M., Rupnik, M., and Cencic, A. (2010). Pancreatic beta cell lines and their applications in diabetes mellitus research. ALTEX 27, 105-113.
70. Stebbings, R., Findlay, L., Edwards, C., et al. (2007). "Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics. J. Immunol. 179, 3325-3331.
71. Stiegler, N. V., Krug, A. K., Matt, F., and Leist, M. (2011). Assessment of chemical-induced impairment of human neurite outgrowth by multiparametric live cell imaging in high-density cultures. Toxicol. Sci. 121, 73-87.
72. Stingl, L., Volkel, M., and Lindl, T. (2009). 20 Years of hypertension research using genetically modified animals: no clinically promising approaches in sight. ALTEX 26, 41-51.
73. Stokes, W. S. and Wind, M. (2010). Validation of innovative technologies and strategies for regulatory safety assessment methods: challenges and opportunities. ALTEX 27, 87-95.
74. Ullrich, A., Stolz, D. B., Ellis, E. C., et al. (2009). Long term cultures of primary human hepatocytes as an alternative to drug testing in animals. ALTEX 26, 295-302.
75. van Ravenzwaay, B. (2010). Initiatives to decrease redundancy in animal testing of pesticides. ALTEX 27, 159-161.
76. stcentury. ALTEX 28, 17-44.
77. Vedani, A., Smiesko, M., Spreafico, M., et al. (2009). VirtualTox- Lab - in silico prediction of the toxic (endocrine-disrupting) potential of drugs, chemicals and natural products. Two years and 2,000 compounds of experience: a progress report. ALTEX 26, 167-176.
78. Vogel, R. (2009). Alternatives to the use of animals in safety testing as required by the EU-Cosmetics Directive 2009. ALTEX 26, 223-226.
79. Zimmer, B., Schildknecht, S., Kuegler, P. B., et al. (2011). Sensitivity of dopaminergic neuron differentiation from stem cells to chronic low-dose methylmercury exposure. Toxicol. Sci. 121, 357-367.